GO:0004649 poly(ADP-ribose) glycohydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004649 describes the enzymatic activity that hydrolyzes poly(ADP-ribose) at the ribose-ribose (1''-2') glycosidic bond to release free ADP-ribose.
• The enzyme responsible, PARG, counteracts PARP-mediated poly(ADP-ribosylation) and is essential for DNA replication, genome stability, and DNA repair.
• PARG dysfunction or inhibition alters osteoclast and osteoblast differentiation, linking the enzyme to bone remodeling.
• PARG has both catalytic and non-catalytic roles in meiosis, coordinating DNA double-strand break induction and repair.
• PARG can act as an oncogene in certain cancers, making it a potential therapeutic target.
• Studying GO:0004649 requires tools such as CRISPR knockout, point-mutation, knock-in, overexpression, and CRISPR library screening, combined with proteomics and imaging.
Description
Poly(ADP-ribose) glycohydrolase (PARG) activity, annotated as GO:0004649, is the enzymatic function that reverses poly(ADP-ribosylation) by cleaving the ribose-ribose bonds of poly(ADP-ribose) (PAR) to generate free ADP-ribose. This activity is critical because PAR polymers are rapidly synthesized by PARP enzymes in response to DNA damage and other stresses, and their timely removal is required for normal cellular function. The balance between PAR synthesis and degradation influences DNA replication, repair, transcription, and cell death. Researchers study GO:0004649 to understand how cells regulate PAR turnover and how disruption of this activity contributes to cancer, bone disease, and developmental defects. PARG is not merely a scavenger; it also participates in processes such as DNA replication and meiosis, sometimes independently of its catalytic activity. This article provides a research-grade overview of the molecular mechanism, key genes, disease links, and experimental models used to investigate poly(ADP-ribose) glycohydrolase activity, with a focus on CRISPR-based approaches for functional genomics.
poly(ADP-ribose) glycohydrolase activity At A Glance
| GO ID | GO:0004649 |
|---|---|
| GO term | poly(ADP-ribose) glycohydrolase activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Catalysis of the hydrolysis of poly(ADP-ribose) at glycosidic (1''-2') linkage of ribose-ribose bond to produce free ADP-ribose. |
| Major function | Degradation of poly(ADP-ribose) polymers, reversing PARP-mediated ADP-ribosylation. |
| Representative enzyme | PARG (poly(ADP-ribose) glycohydrolase) |
| Substrate | Poly(ADP-ribose) (PAR) |
| Product | Free ADP-ribose |
| Cellular processes | DNA replication, DNA repair, genome stability, meiosis, osteoclast/osteoblast differentiation. |
What Is GO:0004649?
GO:0004649, poly(ADP-ribose) glycohydrolase activity, is defined as the catalysis of the hydrolysis of poly(ADP-ribose) at the glycosidic (1''-2') linkage of the ribose-ribose bond, producing free ADP-ribose. In other words, it is the enzymatic activity that breaks down PAR chains by cleaving the unique ribose-ribose bonds that connect ADP-ribose units.
Why Is poly(ADP-ribose) glycohydrolase activity Important in Cell Biology?
Poly(ADP-ribose) glycohydrolase activity is essential for maintaining the dynamic balance of poly(ADP-ribosylation), a post-translational modification that controls DNA damage responses, replication, and cell survival. Dysregulation of this activity is implicated in cancer, where PARG can promote oncogenesis, and in bone remodeling, where it affects osteoclast and osteoblast differentiation. Understanding GO:0004649 therefore has broad implications for cancer biology, bone disease, and genome maintenance.
• Reverses PARP-mediated poly(ADP-ribosylation), preventing excessive PAR accumulation that can be toxic.
• Required for efficient DNA replication through dePARylation of PCNA.
• Supports genome stability by facilitating DNA repair.
• Plays a role in meiosis, including DNA double-strand break induction and repair.
• Modulates osteoclast differentiation, affecting bone resorption.
• Influences osteoblast differentiation and bone formation.
• Can act as an oncogene, making it a potential cancer drug target.
• Its catalytic and non-catalytic functions can be separated, as shown in meiosis.
• Provides a mechanism for rapid and local control of PAR signaling.
• Is a key node in the PARP-PARG cycle that is being explored for therapeutic intervention.
What Happens During poly(ADP-ribose) glycohydrolase activity?
Substrate recognition and binding
In simple terms: The enzyme grabs onto the PAR chain.
PARG binds to poly(ADP-ribose) polymers that are attached to target proteins or exist as free chains. The enzyme recognizes the ribose-ribose linkages within the PAR chain, positioning the glycosidic bond for cleavage.
Catalytic hydrolysis of ribose-ribose bonds
In simple terms: The enzyme cuts the PAR chain into individual ADP-ribose units.
The catalytic activity of PARG hydrolyzes the (1''-2') glycosidic bond between ADP-ribose units, releasing free ADP-ribose. This exo-glycohydrolase activity shortens PAR chains processively, ultimately removing them from proteins.
Release of free ADP-ribose and protein dePARylation
In simple terms: The target protein is freed from the PAR tag.
As PAR chains are degraded, the modified protein is dePARylated, allowing it to resume its normal function. For example, dePARylation of PCNA by PARG is essential for DNA replication.
Coordination with PARP enzymes
In simple terms: PARG works opposite to PARP enzymes to keep PAR levels balanced.
PARG activity counteracts PARP-mediated synthesis of PAR. This balance is critical because PARP enzymes are activated by DNA damage and synthesize PAR rapidly, while PARG removes it to allow repair and replication to proceed.
Non-catalytic roles in meiosis
In simple terms: PARG can have jobs that do not require its cutting activity.
In meiosis, PARG coordinates DNA double-strand break induction and repair independently of its catalytic activity, indicating that the protein has additional functions beyond hydrolysis.
Key Genes Involved in GO:0004649 poly(ADP-ribose) glycohydrolase activity
The following genes and proteins are central to poly(ADP-ribose) glycohydrolase activity and its biological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PARG | Primary enzyme with poly(ADP-ribose) glycohydrolase activity | Target for knockout, point mutation, and overexpression studies. |
| PARP1 | Synthesizes poly(ADP-ribose) chains | Counterpart to PARG; studied together to understand PAR balance. |
| PARP2 | Synthesizes poly(ADP-ribose) chains | Contributes to PAR synthesis and DNA repair. |
| PCNA | Processivity factor for DNA replication; dePARylated by PARG | Used to study PARG-dependent dePARylation in replication. |
| RANKL | Cytokine that stimulates osteoclast differentiation | Used to study PARG in osteoclastogenesis. |
| NFATc1 | Transcription factor in osteoclast differentiation | Downstream of RANKL; affected by PARG dysfunction. |
| RUNX2 | Transcription factor in osteoblast differentiation | Used to study PARG inhibition in osteoblasts. |
| Osterix | Transcription factor in osteoblast differentiation | Marker of osteoblast differentiation in PARG studies. |
| DMC1 | Meiotic recombinase | Studied in PARG mutants during meiosis. |
| RAD51 | Homologous recombination repair protein | Related to PARG function in DNA repair. |
| ATM | DNA damage response kinase | Coordinates with PARP/PARG in DNA damage signaling. |
| XRCC1 | Base excision repair protein | Interacts with PAR metabolism. |
| BRCA1 | Homologous recombination repair | Potential synthetic lethality with PARG inhibition. |
| BRCA2 | Homologous recombination repair | Potential synthetic lethality with PARG inhibition. |
| MRE11 | DNA double-strand break repair | Studied in meiosis with PARG. |
| NBS1 | MRN complex component | Related to DNA damage response. |
| CDK1 | Cell cycle kinase | May regulate PARG during replication. |
| AIF | Apoptosis-inducing factor | Can act as a PAR-degrading enzyme in some contexts. |
How Is poly(ADP-ribose) glycohydrolase activity Regulated?
PARG activity is regulated at multiple levels. Its catalytic activity can be modulated by post-translational modifications and by interaction with other proteins. During the cell cycle, PARG may be regulated to ensure timely dePARylation of replication factors such as PCNA. In meiosis, PARG function is required independently of its catalytic activity, suggesting that protein-protein interactions or localization also control its roles. Additionally, the balance between PARP and PARG activities is critical, and changes in either enzyme affect the other.
poly(ADP-ribose) glycohydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PARG | Cancer (oncogenic activity) | PARG knockout or overexpression in cancer cell lines. |
| PARG | Bone remodeling disorders | PARG knockout in RAW264.7 osteoclast precursors. |
| PARG | Bone formation disorders | PARG inhibition in MC3T3-E1 preosteoblasts. |
| PARG | Meiotic defects / infertility | PARG mutant mouse models. |
| PARG | DNA replication stress | PARG knockout cells with PCNA dePARylation assays. |
Cancer
PARG can exhibit oncogenic activity, promoting tumor cell survival and proliferation. Its ability to reverse PARP-mediated PARylation makes it a potential target for cancer therapy, especially in tumors with DNA repair defects.
Bone disorders
Dysfunction of PARG suppresses osteoclast differentiation, which could affect bone resorption and lead to osteopetrosis-like phenotypes. Conversely, inhibition of PARG accelerates osteoblast differentiation, suggesting a complex role in bone remodeling.
Meiotic defects and infertility
PARG is required for proper meiotic DNA double-strand break induction and repair, and its loss can lead to meiotic defects and potentially infertility.
Neurodegeneration
Although direct evidence is limited, the PARP-PARG cycle is implicated in neuronal survival and death, and dysregulation of PAR metabolism may contribute to neurodegenerative conditions.
From poly(ADP-ribose) glycohydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic role of PARG in DNA replication? | PARG knockout cell lines complemented with wild-type or catalytically dead PARG. |
| Does PARG have non-catalytic functions in meiosis? | PARG point mutant (catalytically inactive) knock-in mice. |
| How does PARG affect osteoclast differentiation? | PARG knockout or knockdown in RAW264.7 cells. |
| How does PARG inhibition affect osteoblast differentiation? | PARG inhibitor treatment in MC3T3-E1 cells. |
| Is PARG oncogenic in specific cancers? | PARG overexpression or knockout in cancer cell lines and xenografts. |
| What proteins interact with PARG? | Tagged knock-in of PARG followed by immunoprecipitation. |
How to Study the poly(ADP-ribose) glycohydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of PARG protein and activity | Study of PARG requirement in DNA replication and repair. |
| Point mutation knock-in | Catalytic vs non-catalytic functions | Meiosis studies. |
| Overexpression | Gain of function | Oncogenic potential. |
| Immunoblotting | PAR levels and PARG expression | DNA damage response. |
| Proteomics | PARylated protein identification | DePARylation targets. |
| Immunofluorescence | Subcellular localization | PARG and PAR dynamics. |
| Differentiation assays | Osteoclast/osteoblast differentiation | Bone biology. |
| CRISPR library screening | Genome-wide modifiers of PARG sensitivity | Drug target discovery. |
CRISPR knockout and point mutation
CRISPR-Cas9 can generate PARG knockout cells to study loss of poly(ADP-ribose) glycohydrolase activity. Point mutations in the catalytic domain can separate catalytic from non-catalytic functions.
Overexpression and knock-in
Overexpression of wild-type or mutant PARG allows assessment of gain-of-function effects. Tagged knock-in enables localization and interaction studies.
Proteomics and PARylation assays
Mass spectrometry-based proteomics can identify PARylated proteins and quantify changes upon PARG manipulation. Western blotting with anti-PAR antibodies measures PAR levels.
Imaging and cell-based assays
Fluorescence microscopy can visualize PAR and PARG localization. Differentiation assays (e.g., TRAP staining for osteoclasts, ALP staining for osteoblasts) assess PARG roles in bone cells.
How CRISPR Can Be Used to Study GO:0004649 poly(ADP-ribose) glycohydrolase activity
Knockout
CRISPR knockout of PARG eliminates poly(ADP-ribose) glycohydrolase activity, causing PAR accumulation and defects in DNA replication and repair. Knockout models are used to study loss-of-function phenotypes in cancer and bone cells.
Point Mutation
Introducing point mutations in the catalytic domain of PARG allows researchers to distinguish catalytic activity from non-catalytic functions, as demonstrated in meiosis.
Knock-in
Knock-in of tagged PARG (e.g., GFP or FLAG) enables visualization and immunoprecipitation of the enzyme to study its interactions and localization.
Overexpression
Overexpression of PARG can reveal oncogenic roles and effects on PAR balance. It is also used to rescue knockout phenotypes.
How EDITGENE Supports poly(ADP-ribose) glycohydrolase activity Research
Researchers studying poly(ADP-ribose) glycohydrolase activity-related genes often need to determine whether a candidate gene is causally involved in PAR metabolism, DNA repair, or bone differentiation. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for poly(ADP-ribose) glycohydrolase activity research.
Frequently Asked Questions About poly(ADP-ribose) glycohydrolase activity
What is poly(ADP-ribose) glycohydrolase activity?
It is the enzymatic activity that hydrolyzes poly(ADP-ribose) at ribose-ribose bonds to produce free ADP-ribose, encoded by GO:0004649.
What gene encodes poly(ADP-ribose) glycohydrolase activity?
The primary gene is PARG, which encodes the enzyme responsible for this activity.
What diseases are associated with PARG dysfunction?
PARG dysfunction is linked to cancer, bone remodeling disorders, and meiotic defects.
How is poly(ADP-ribose) glycohydrolase activity regulated?
It is regulated by post-translational modifications, protein interactions, and the balance with PARP enzymes.
What is the role of PARG in DNA replication?
PARG dePARylates PCNA, which is essential for DNA replication.
Can PARG have non-catalytic functions?
Yes, in meiosis PARG coordinates DNA double-strand break induction and repair independently of its catalytic activity.
What experimental models are used to study PARG?
Knockout, point mutation, knock-in, and overexpression models in cell lines and mice are commonly used.
How does PARG affect bone cells?
PARG dysfunction suppresses osteoclast differentiation and inhibition of PARG accelerates osteoblast differentiation.
Is PARG a potential drug target?
Yes, PARG is considered a therapeutic target in cancer due to its oncogenic activity.
What methods measure poly(ADP-ribose) glycohydrolase activity?
Methods include immunoblotting for PAR, proteomics, and cell-based assays.
Conclusion
Poly(ADP-ribose) glycohydrolase activity (GO:0004649) is a fundamental enzymatic function that counteracts PARP-mediated poly(ADP-ribosylation), influencing DNA replication, repair, meiosis, and bone cell differentiation. Its dysregulation is implicated in cancer and bone disorders, making it an attractive target for therapeutic intervention. Continued research using CRISPR-based models will further elucidate its mechanistic roles and potential as a drug target.
References
- 1. Marques M et al.. 2019. Oncogenic activity of poly (ADP-ribose) glycohydrolase.. Oncogene 38(12):2177-2191 PMID: 30459355
- 2. Yan Z et al.. 2025. Poly (ADP-Ribose) Glycohydrolase-Dependent dePARylation of PCNA Is Essential for DNA Replication.. FASEB J 39(16):e70959 PMID: 40827866
- 3. Sasaki Y et al.. 2024. Dysfunction of poly (ADP-ribose) glycohydrolase suppresses osteoclast differentiation in RANKL-stimulated RAW264 cells.. Biochem Biophys Res Commun 692:149309 PMID: 38048727
- 4. Janisiw E et al.. 2020. Poly(ADP-ribose) glycohydrolase coordinates meiotic DNA double-strand break induction and repair independent of its catalytic activity.. Nat Commun 11(1):4869 PMID: 32978394
- 5. Sasaki Y et al.. 2022. Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells.. Int J Mol Sci 23(9) PMID: 35563432
- 6. Bürkle A et al.. 2013. Poly(ADP-ribose): PARadigms and PARadoxes.. Mol Aspects Med 34(6):1046-65 PMID: 23290998
- 8. Meyer-Ficca ML et al.. 2005. Poly(ADP-ribose) polymerases: managing genome stability.. Int J Biochem Cell Biol 37(5):920-6 PMID: 15743666
